Press review
The essentials of recent medical publications, unpacked by our newsroom into a clear, sourced digest, specialty by specialty.
Public Health and Social MedicineStress and its impacts on brain alterations: toward a better understanding of ADHD
Attention-Deficit / Hyperactivity Disorder (ADHD) is a complex neurodevelopmental disorder influenced by both genetic and environmental factors. Among these, stress—whether prenatal or postnatal—plays a pivotal role in the brain alterations associated with ADHD. This stress can result from traumatic experiences, adverse socioeconomic conditions, or exposure to harmful substances. This study invest
InfectiologyCombating antifungal-resistant oral candidiasis in HIV patients: current challenges and innovative solutions
Oral Candidiasis (OC) remains one of the most prevalent opportunistic infections among individuals living with HIV. Despite significant advancements in antiretroviral therapy, the emergence of antifungal-resistant Candida strains poses a serious challenge to effective disease management. This growing concern underscores the urgent need for innovative therapeutic alternatives. This study explores t
OncologyA breakthrough in pancreatic cancer treatment: evaluation of a new dual therapy
Pancreatic ductal adenocarcinoma (PDA) is one of the leading causes of cancer-related mortality. This malignancy is characterized by its resistance to conventional treatments and immune checkpoint inhibitors (ICIs). Due to its late detection, poor long-term survival rate, and rising incidence, identifying new therapeutic approaches remains a critical priority. In this context, this study investiga
NeurologyFever and acute non-anoxic brain injuries: clinical challenges and intervention strategies
Managing acute non-anoxic brain injuries, including hemorrhagic or ischemic strokes and traumatic brain injuries, poses a significant challenge in neurology. This challenge is compounded by the fact that fever, present in nearly 90% of patients in intensive care, is closely linked to severe neurological complications. Understanding the impact of fever on clinical outcomes is essential to optimizin
Allergology and ImmunologyReprogramming the Tumor Microenvironment: A New Era for Viro-Immunotherapy
Oncolytic virus therapy, such as herpes simplex virus 1 (oHSV), has shown promising results in treating cancers like glioblastoma (GBM) and breast cancer brain metastases (BCBM). However, its effectiveness is often limited by the resistance of tumor cells and their microenvironment (TME). A major breakthrough has identified the growth factor IGF2, induced by oHSV, as a key player in this resistanc
OphthalmologySurgical Management of Rhegmatogenous Retinal Detachment
Rhegmatogenous retinal detachment (RRD) is a common ophthalmic emergency, with an annual incidence of 7.9 to 18.2 cases per 100,000 individuals. Caused by a retinal tear, this condition can lead to blindness without prompt and appropriate intervention. Surgery remains the cornerstone of treatment, but the optimal choice among available options is still debated. This study provides a comparative ev
OncologyColon Cancer: a new therapeutic breakthrough?
Colorectal cancer (CRC) ranks among the most common and deadly cancers worldwide. Despite therapeutic advances, particularly through the combination of surgery and chemotherapy, two major challenges persist: treatment resistance and tumor recurrence. Addressing these limitations, an innovative strategy has emerged: combining the inhibition of O-GlcNAcylation, a key post-translational modification,
Public Health and Social MedicineClindamycin and postoperative infections: towards more effective prophylaxis?
Surgical site infections (SSIs) remain a common complication in minor surgeries, significantly impacting patient recovery. In the context of rising antibiotic resistance, exploring innovative prophylactic approaches, such as the use of clindamycin, is becoming increasingly crucial. This study examines the effectiveness of clindamycin, a broad-spectrum antibiotic, in reducing bacterial load as a pr
OncologyA promising breakthrough in cancer cachexia treatment
Cancer cachexia is a common and severe cancer complication characterized by significant weight and muscle loss, often associated with increased morbidity and mortality. Recent research highlights the central role of growth differentiation factor 15 (GDF-15) in its pathophysiology. Ponsegromab, a humanized monoclonal antibody targeting and inhibiting GDF-15, has shown promising effects, including i
InfectiologyA promising breakthrough against antibiotic resistance
Antimicrobial resistance (AMR) is a major global health threat, causing nearly 5 million deaths in 2019. Given the urgency, identifying new treatments is more critical than ever. In this context, BWC0977, a bacterial topoisomerase inhibitor, emerges as an innovative therapeutic candidate effective against pathogens resistant to conventional treatments. With a broad spectrum of activity and demonst
OncologyImmune checkpoint inhibitor therapy: a major breakthrough in treating triple-negative breast cancer
Triple-negative breast cancer (TNBC) is an aggressive and challenging subtype of breast cancer characterized by poor prognosis and limited treatment options. Conventional therapies, primarily based on chemotherapy, often prove ineffective and are associated with significant side effects. Against this backdrop, the emergence of immune checkpoint inhibitors (ICI), such as PD-1/PD-L1 inhibitors, has
SurgeryDown Syndrome and Postoperative Management: Toward Optimized Approaches in Analgesia and Sedation
Down syndrome (trisomy 21) is a chromosomal anomaly associated with physiological characteristics that can affect responses to analgesics and sedatives. Postoperative pain and sedation management for these patients thus present a significant challenge for healthcare professionals. This is further complicated by conflicting findings from earlier studies regarding opioid and benzodiazepine requireme